Proposed Directors of Tirupati Graphite explain why they have requisitioned an GM. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIndivior Share News (INDV)

Share Price Information for Indivior (INDV)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,383.00
Bid: 1,398.00
Ask: 1,400.00
Change: -35.00 (-2.47%)
Spread: 2.00 (0.143%)
Open: 1,412.00
High: 1,433.00
Low: 1,383.00
Prev. Close: 1,418.00
INDV Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Indivior appoints Ryan Preblick as CFO

Fri, 20th Nov 2020 11:34

(Sharecast News) - Indivior has appointed Ryan Preblick as chief financial officer after he spent five months in the job on an interim basis.
Preblick has had senior finance jobs at the prescription drugs company since joining in 2012. He takes over from Mark Crossley who stepped up to become chief executive in June.

Before standing in as CFO Preblick was Indivior's senior vice president of global financial planning for commercial operations. Indivior said that job included overseeing financial management, analysis and reporting of the group's global business.

Preblick's appointment puts a new senior team in place after turbulence caused by a long-running legal case in the US over fraudulent marketing of Indivior's opioid addiction treatment. Shaun Thaxter stood down as CEO in June and was sent to jail for six months after pleading guilty to a criminal charge related to sales of the Suboxone treatment.

Crossley said: "Ryan has proven to be a highly capable leader of our finance organisation and has performed strongly in his role as interim chief financial officer. The board and I are delighted to confirm his appointment as chief financial officer and executive director."

Indivior agreed in July to pay the US Department of Justice and other authorities $600m over seven years and plead guilty to a felony charge to settle the Suboxone case. A federal court approved the agreement on 13 November, drawing a line under a matter that has hung over the company for most of the time since it split from Reckitt Benckiser in 2014.

Preblick started his career in corporate finance at Honeywell International and then worked for 12 years at cigarette company Altria.
More News
28 Oct 2021 12:17

Indivior lifts FY guidance as Q3 profits, revenue jump

(Sharecast News) - Indivior lifted its full-year guidance on Thursday as it reported a rise in third-quarter revenue and profit.

Read more
24 Oct 2021 17:12

Sunday share tips: Light Science Technologies, Indivior

(Sharecast News) - The Financial Mail on Sunday's Midas column told readers to buy shares of Light Science Technologies, pointing out the benefits of the company's technology for health, climate and the UK more economy.

Read more
31 Aug 2021 09:38

LONDON BROKER RATINGS: Citi and JPMorgan differ on Bridgepoint

LONDON BROKER RATINGS: Citi and JPMorgan differ on Bridgepoint

Read more
11 Aug 2021 16:08

Director dealings: Indivior director ups stake

(Sharecast News) - Indivior revealed on Wednesday that non-executive director Mark Stejbach had acquired 36,000 ordinary shares in the FTSE 250-listed pharmaceuticals business.

Read more
10 Aug 2021 15:07

DIRECTOR DEALINGS: 3i team buy; Scopia trims Indivior stake further

DIRECTOR DEALINGS: 3i team buy; Scopia trims Indivior stake further

Read more
9 Aug 2021 13:03

DIRECTOR DEALINGS: IntegraFin COO sells; Chaarat Gold chair buys

DIRECTOR DEALINGS: IntegraFin COO sells; Chaarat Gold chair buys

Read more
5 Aug 2021 15:29

DIRECTOR DEALINGS: Scopia slims 16% Indivior stake as chair buys

DIRECTOR DEALINGS: Scopia slims 16% Indivior stake as chair buys

Read more
4 Aug 2021 14:23

DIRECTOR DEALINGS: Robert Walters CEO sells GBP2.8 million in shares

DIRECTOR DEALINGS: Robert Walters CEO sells GBP2.8 million in shares

Read more
30 Jul 2021 12:28

IN BRIEF: Indivior to commence USD100 million share repurchase program

IN BRIEF: Indivior to commence USD100 million share repurchase program

Read more
29 Jul 2021 15:37

IN BRIEF: Indivior unveils profit hike and USD100 million buyback

IN BRIEF: Indivior unveils profit hike and USD100 million buyback

Read more
29 Jul 2021 12:13

LONDON MARKET MIDDAY: Investors cheer dividend hikes and buyback plans

LONDON MARKET MIDDAY: Investors cheer dividend hikes and buyback plans

Read more
29 Jul 2021 08:48

Indivior launches share buyback after strong first half

(Sharecast News) - Speciality pharmaceuticals company Indivior reiterated its upgraded guidance for 2021 on Thursday, and announced the start of a $100m (£71.71m) share buyback programme, as its first-half net revenue rose to $381m from $303m year-on-year.

Read more
22 Jul 2021 16:03

UK earnings, trading statements calendar - next 7 days

UK earnings, trading statements calendar - next 7 days

Read more
1 Jul 2021 14:00

Indivior agrees new loan facilities of USD250 million maturing in 2026

Indivior agrees new loan facilities of USD250 million maturing in 2026

Read more
1 Jul 2021 10:33

Indivior agrees to reprice and extend maturity of term loan facilities

(Sharecast News) - Pharmaceutical firm Indivior said on Thursday that it had entered into an amendment to reprice and extend the maturity of $250.0m worth of term loan facilities.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.